Safety and Efficacy on Cell-based Therapy in Patients With Recent Large Acute Myocardial Infarction

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2009

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Acute Myocardial InfarctionHeart Failure
Interventions
BIOLOGICAL

Intracoronary delivery of unfractionated bone marrow mononuclear cells

Maximal intracoronary cell dose: 50 x 10e7 cells diluted in 10 ml Maximal intracoronary volume: 10 ml (diluted in plasma and culture medium)

BIOLOGICAL

Placebo

Plasma and culture medium (10 ml)

Sponsors
All Listed Sponsors
collaborator

Duke Clinical Research Institute

OTHER

lead

Duke University

OTHER